MYCOKEM

This brand name is authorized in Hong Kong SAR China, South Africa.

Active ingredients

The drug MYCOKEM contains one active pharmaceutical ingredient (API):

1	Mycophenolate mofetil UNII 9242ECW6R0 - MYCOPHENOLATE MOFETIL
	Mycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA). MPA is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA.
	Read more about Mycophenolate mofetil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MYCOKEM 500 Film-coated tablet	MPI, EU: SmPC	Pharmaceutical Benefits Scheme (AU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AA06	Mycophenolic acid	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants
Discover more medicines within L04AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	64856, 65788
ZA	Health Products Regulatory Authority	44/32.2/0631, 45/32.2/0221